<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="review-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/ms2024-398</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-8659</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ИНФЕКЦИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>INFECTIONS</subject></subj-group></article-categories><title-group><article-title>Доказательная медицина: индол-3-карбинол и ресвератрол при состояниях, ассоциированных с вирусом папилломы человека</article-title><trans-title-group xml:lang="en"><trans-title>Evidence-based medicine: Indole-3-carbinol and resveratrol in human papillomavirus-associated conditions</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8885-1587</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Енькова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Enkova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Енькова Елена Владимировна, д.м.н., профессор кафедры акушерства и гинекологии №2</p><p>394036, Воронеж, ул. Студенческая, д. 10</p></bio><bio xml:lang="en"><p>Elena V. Enkova, Dr. Sci. (Med.), Professor of the Department of Obstetrics and Gynecology No. 2</p><p>10, Studencheskaya St., Voronezh, 394036</p></bio><email xlink:type="simple">enkova@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4199-8156</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хоперская</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Khoperskaya</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Хоперская Ольга Викторовна, к.м.н., доцент кафедры акушерства и гинекологии №2</p><p>394036, Воронеж, ул. Студенческая, д. 10</p></bio><bio xml:lang="en"><p>Olga V. Khoperskaya, Cand. Sci. (Med.), Associate Professor of the Department of Obstetrics and Gynecology No. 2</p><p>10, Studencheskaya St., Voronezh, 394036</p></bio><email xlink:type="simple">khoperskaya88@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9259-180X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шамарин</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shamarin</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шамарин Станислав Вячеславович, к.м.н., доцент кафедры акушерства и гинекологии №2</p><p>394036, Воронеж, ул. Студенческая, д. 10</p></bio><bio xml:lang="en"><p>Stanislav V. Shamarin, Cand. Sci. (Med.), Associate Professor of the Department of Obstetrics and Gynecology No. 2</p><p>10, Studencheskaya St., Voronezh, 394036</p></bio><email xlink:type="simple">shamarin-med@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3383-5755</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Енькова</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Enkova</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Енькова Валерия Вадимовна, к.м.н., доцент кафедры акушерства и гинекологии №2</p><p>394036, Воронеж, ул. Студенческая, д. 10</p></bio><bio xml:lang="en"><p>Valeria V. Enkova, Cand. Sci. (Med.), Associate Professor of the Department of Obstetrics and Gynecology No. 2</p><p>10, Studencheskaya St., Voronezh, 394036</p></bio><email xlink:type="simple">enkova_lera@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-4033-516X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Асеев</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Aseev</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Асеев Александр Вадимович, студент лечебного факультета</p><p>394036, Воронеж, ул. Студенческая, д. 10</p></bio><bio xml:lang="en"><p>Alexandr V. Aseev, Student of the Faculty of Medicine</p><p>10, Studencheskaya St., Voronezh, 394036</p></bio><email xlink:type="simple">al-aseev@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Воронежский государственный медицинский университет им. Н.Н. Бурденко</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Voronezh State Medical University named after N.N. Burdenko</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>07</day><month>11</month><year>2024</year></pub-date><volume>0</volume><issue>17</issue><fpage>74</fpage><lpage>81</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Енькова Е.В., Хоперская О.В., Шамарин С.В., Енькова В.В., Асеев А.В., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Енькова Е.В., Хоперская О.В., Шамарин С.В., Енькова В.В., Асеев А.В.</copyright-holder><copyright-holder xml:lang="en">Enkova E.V., Khoperskaya O.V., Shamarin S.V., Enkova V.V., Aseev A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/8659">https://www.med-sovet.pro/jour/article/view/8659</self-uri><abstract><p>Из всех видов рака женской репродуктивной системы рак шейки матки имеет наибольшее социальное значение ввиду того, что поражает молодых пациенток, часто даже еще не выполнивших репродуктивную функцию, и является третьей по значимости причиной смерти от рака. Учитывая отсутствие этиотропной терапии вируса папилломы человека и ассоциированных с вирусом заболеваний, высокоэффективных методов медикаментозной терапевтической поддержки и золотого стандарта лечения, кроме деструктивных и эксцизионных методов, представляется целесообразным рассмотреть применение нутриентов, обладающих антиканцерогенным действием при лечении цервикальных интраэпителиальных неоплазий легкой степени как в дополнение к выжидательной тактике, так и при применении аблативных методов лечения, а также их адъювантное назначение при облигатном предраке. На основании отечественных и зарубежных литературных источников из электронных баз PubMed, CyberLeninka, Elibrary в обзоре представлены данные о применении транс-ресвератрола и индол-3-карбинола при ассоциированных с вирусом папилломы человека заболеваниях. Комбинация из двух взаимно дополняющих антиканцерогенных антиоксидантов – индол-3-карбинола, обладающего преимущественно антипролиферативным действием, и транс-ресвератрола, восстанавливающего клеточные механизмы апоптоза, – комплексно воздействует на патогенетические механизмы вирус-индуцированного патологического процесса: доказанно снижает экспрессию онкогенов Е6 и Е7, повышает экспрессию белков – супрессоров опухолей p53, pRb, PTEN и снижает – маркеров пролиферации PCNA и Ki-67. Комбинация 200 мг индол-3-карбинола и 60 мг транс-ресвератрола для профилактики персистенции папилломавирусной инфекции и лечения цервикальных интраэпителиальных неоплазий обладает впечатляющим потенциалом, однако необходимы дальнейшие исследования для подбора наиболее эффективных схем применения.</p></abstract><trans-abstract xml:lang="en"><p>Of all types of cancer in the female reproductive system, cervical cancer has the greatest social significance due to its impact on young patients, often even those who have not yet completed their reproductive function, and it is the third leading cause of cancer-related death. Considering the lack of etiological therapy for human papillomavirus and associated diseases, the high demand for effective methods of medical therapeutic support, and the absence of a gold standard treatment apart from destructive and excisional methods, it seems reasonable to consider the use of nutrients with anticancer effects in the treatment of low-grade cervical intraepithelial neoplasia both as an addition to the watchful waiting strategy and in the use of ablative treatment methods, as well as their adjuvant appointment in the case of obligatory precancer. Based on domestic and foreign literature sources from electronic databases such as PubMed, CyberLeninka, and Elibrary, this review presents data on the use of trans-resveratrol and indole-3-carbinol in HPV-associated diseases. The combination of two mutually complementary anticancer antioxidants – indole-3-carbinol, which primarily has antiproliferative effects, and trans-resveratrol, which restores cellular apoptosis mechanisms, comprehensively affects the pathogenetic mechanisms of the virus-induced pathological process: it has been proven to reduce the expression of oncogenes E6 and E7, increase the expression of tumor suppressor proteins – p53, pRb, PTEN, and decrease markers of proliferation PCNA and Ki-67. The combination of 200 mg of indole-3-carbinol and 60 mg of trans-resveratrol for the prevention of persistent papillomavirus infection and the treatment of cervical intraepithelial neoplasia has impressive potential; however, further research is needed to determine the most effective application schemes.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>индол-3-карбинол</kwd><kwd>ресвератрол</kwd><kwd>транс-ресвератрол</kwd><kwd>рак шейки матки</kwd><kwd>папилломавирусная инфекция</kwd><kwd>цервикальные неоплазии</kwd><kwd>CIN</kwd></kwd-group><kwd-group xml:lang="en"><kwd>indole-3-carbinol</kwd><kwd>resveratrol</kwd><kwd>trans-resveratrol</kwd><kwd>cervical cancer</kwd><kwd>papillomavirus infection</kwd><kwd>cervical neoplasia</kwd><kwd>CIN</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Murray CJL. The Global Burden of Disease Study at 30 years. Nat Med. 2022;28(10):2019–2026. https://doi.org/10.1038/s41591-022-01990-1.</mixed-citation><mixed-citation xml:lang="en">Murray CJL. The Global Burden of Disease Study at 30 years. Nat Med. 2022;28(10):2019–2026. https://doi.org/10.1038/s41591-022-01990-1.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Shafabakhsh R, Reiter RJ, Aschner M, Mirzaei H, Asemi Z. Resveratrol and Cervical Cancer: A New Therapeutic Option. Mini Rev Med Chem. 2023;23(2):159–169. https://doi.org/10.2174/1389557522666220128155525.</mixed-citation><mixed-citation xml:lang="en">Shafabakhsh R, Reiter RJ, Aschner M, Mirzaei H, Asemi Z. Resveratrol and Cervical Cancer: A New Therapeutic Option. Mini Rev Med Chem. 2023;23(2):159–169. https://doi.org/10.2174/1389557522666220128155525.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Шахзадова АО, Старинский ВВ, Лисичникова ИВ. Состояние онкологической помощи населению России в 2022 году. Сибирский онкологический журнал. 2023;22(5):5–13. https://doi.org/10.21294/1814-4861-2023-22-5-5-13.</mixed-citation><mixed-citation xml:lang="en">Shakhzadova AO, Starinsky VV, Lisichnikova IV. Cancer care to the population of Russia in 2022. Siberian Journal of Oncology. 2023;22(5):5–13. (In Russ.) https://doi.org/10.21294/1814-4861-2023-22-5-5-13.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Енькова ЕВ, Хоперская ОВ, Енькова ВВ, Карпова ДВ. Распространенность ВПЧ в популяции женщин города Воронежа. Вопросы практической кольпоскопии. Генитальные инфекции. 2022;(4):42–45. https://doi.org/10.46393/27826392_2022_4_42.</mixed-citation><mixed-citation xml:lang="en">Enkova EV, Khoperskaya OV, Enkova VV, Karpova DV. The prevalence of HPV in the population of women of Voronezh. Issues of Practical Colposcopy &amp; Genital Infections. 2022;(4):42–45. (In Russ.) https://doi.org/10.46393/27826392_2022_4_42.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Енькова ЕВ, Киселева ЕВ, Хоперская ОВ, Шамарин СВ, Духанина ЕС, Сенцова ЕЯ. Вакцинация против вируса папилломы человека – основополагающий фактор профилактики рака шейки матки (обзор). Научные результаты биомедицинских исследований. 2021;7(2):181–194. https://doi.org/10.18413/2658-6533-2021-7-2-0-9.</mixed-citation><mixed-citation xml:lang="en">Enkova ЕV, Kiseleva ЕV, Khoperskaya OV, Shamarin SV, Dukhanina ES, Sentsova EYa Vaccination against human papillomavirus is a fundamental factor in the prevention of cervical cancer (review). Research Results in Biomedicine. 2021;7(2):181–194. (In Russ.) https://doi.org/10.18413/2658-6533-2021-7-2-0-9.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Хоперская ОВ, Енькова ЕВ, Киселева ЕВ, Шамарин СВ, Сенцова ЕЯ. Диагностические маркеры персистенции вируса папилломы человека и прогрессии цервикальной интраэпителиальной неоплазии. Медицинский совет. 2021;(21-1):242–248. https://doi.org/10.21518/2079-701X-2021-21-1-242-248.</mixed-citation><mixed-citation xml:lang="en">Khoperskaya OV, Enkova EV, Kiseleva EV, Shamarin SV, Sentsova EYa. Diagnostic markers of human papillomavirus persistence and progression of cervical intraepithelial neoplasia. Meditsinskiy Sovet. 2021;(21-1): 242–248. (In Russ.) https://doi.org/10.21518/2079-701X-2021-21-1-242-248.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Athanasiou A, Veroniki AA, Efthimiou O, Kalliala I, Naci H, Bowden S et al. Comparative effectiveness and risk of preterm birth of local treatments for cervical intraepithelial neoplasia and stage IA1 cervical cancer: a systematic review and network meta-analysis. Lancet Oncol. 2022;23(8):1097–1108. https://doi.org/10.1016/S1470-2045(22)00334-5.</mixed-citation><mixed-citation xml:lang="en">Athanasiou A, Veroniki AA, Efthimiou O, Kalliala I, Naci H, Bowden S et al. Comparative effectiveness and risk of preterm birth of local treatments for cervical intraepithelial neoplasia and stage IA1 cervical cancer: a systematic review and network meta-analysis. Lancet Oncol. 2022;23(8):1097–1108. https://doi.org/10.1016/S1470-2045(22)00334-5.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Hashiramoto S, Kinjo T, Tanaka SE, Arai W, Shimada M, Ashikawa K et al. Vaginal Microbiota and Pregnancy Outcomes of Patients with Conization Histories. J Womens Health. 2023;32(3):375–384. https://doi.org/10.1089/jwh.2022.0440.</mixed-citation><mixed-citation xml:lang="en">Hashiramoto S, Kinjo T, Tanaka SE, Arai W, Shimada M, Ashikawa K et al. Vaginal Microbiota and Pregnancy Outcomes of Patients with Conization Histories. J Womens Health. 2023;32(3):375–384. https://doi.org/10.1089/jwh.2022.0440.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lieb JA, Mondal A, Lieb L, Fehm TN, Hampl M. Pregnancy outcome and risk of recurrence after tissue-preserving loop electrosurgical excision procedure (LEEP). Arch Gynecol Obstet. 2023;307(4):1137–1143. https://doi.org/10.1007/s00404-022-06760-5.</mixed-citation><mixed-citation xml:lang="en">Lieb JA, Mondal A, Lieb L, Fehm TN, Hampl M. Pregnancy outcome and risk of recurrence after tissue-preserving loop electrosurgical excision procedure (LEEP). Arch Gynecol Obstet. 2023;307(4):1137–1143. https://doi.org/10.1007/s00404-022-06760-5.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Zhuang H, Hong S, Zheng L, Zhang L, Zhuang X, Wei H, Yang Y. Effects of cervical conisation on pregnancy outcome: a meta-analysis. J Obstet Gynaecol. 2019;39(1):74–81. https://doi.org/10.1080/01443615.2018.1463206.</mixed-citation><mixed-citation xml:lang="en">Zhuang H, Hong S, Zheng L, Zhang L, Zhuang X, Wei H, Yang Y. Effects of cervical conisation on pregnancy outcome: a meta-analysis. J Obstet Gynaecol. 2019;39(1):74–81. https://doi.org/10.1080/01443615.2018.1463206.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Monti M, D’Aniello D, Scopelliti A, Tibaldi V, Santangelo G, Colagiovanni V et al. Relationship between cervical excisional treatment for cervical intraepithelial neoplasia and obstetrical outcome. Minerva Obstet Gynecol. 2021;73(2):233–246. https://doi.org/10.23736/S2724-606X.20.04678-X.</mixed-citation><mixed-citation xml:lang="en">Monti M, D’Aniello D, Scopelliti A, Tibaldi V, Santangelo G, Colagiovanni V et al. Relationship between cervical excisional treatment for cervical intraepithelial neoplasia and obstetrical outcome. Minerva Obstet Gynecol. 2021;73(2):233–246. https://doi.org/10.23736/S2724-606X.20.04678-X.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Pandraklakis A, Thomakos N, Prodromidou A, Oikonomou MD, Papanikolaou IG, Vlachos DG et al. The Conundrum of Prematurity and Pregnancy Outcomes after Fertility Sparing Treatment Modalities for Early Stage Cervical Cancer: A Systematic Review of the Literature. Folia Med. 2020;62(3):453–461. https://doi.org/10.3897/folmed.62.e48736.</mixed-citation><mixed-citation xml:lang="en">Pandraklakis A, Thomakos N, Prodromidou A, Oikonomou MD, Papanikolaou IG, Vlachos DG et al. The Conundrum of Prematurity and Pregnancy Outcomes after Fertility Sparing Treatment Modalities for Early Stage Cervical Cancer: A Systematic Review of the Literature. Folia Med. 2020;62(3):453–461. https://doi.org/10.3897/folmed.62.e48736.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Einstein MH, Schiller JT, Viscidi RP, Strickler HD, Coursaget P, Tan T et al. Clinician’s guide to human papillomavirus immunology: knowns and unknowns. Lancet Infect Dis. 2009;9(6):347–356. https://doi.org/10.1016/S1473-3099(09)70108-2.</mixed-citation><mixed-citation xml:lang="en">Einstein MH, Schiller JT, Viscidi RP, Strickler HD, Coursaget P, Tan T et al. Clinician’s guide to human papillomavirus immunology: knowns and unknowns. Lancet Infect Dis. 2009;9(6):347–356. https://doi.org/10.1016/S1473-3099(09)70108-2.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Хоперская ОВ, Енькова ЕВ, Енькова ВВ, Хатунцев АВ, Карпова ДВ, Обернихин КИ, Селютин АА. Профилактика рака шейки матки у молодых женщин. В: XXXVI Международный конгресс с курсом эндоскопии «Новые технологии в диагностике и лечении гинекологических заболеваний». Москва, 6–9 июня 2023 г. М.: МЕДИ Ивент; 2023. С. 11–12. Режим доступа: https://mediexpo.ru/fileadmin/user_upload/content/pdf/thesis/nt2023-abstracts.pdf.</mixed-citation><mixed-citation xml:lang="en">Хоперская ОВ, Енькова ЕВ, Енькова ВВ, Хатунцев АВ, Карпова ДВ, Обернихин КИ, Селютин АА. Профилактика рака шейки матки у молодых женщин. В: XXXVI Международный конгресс с курсом эндоскопии «Новые технологии в диагностике и лечении гинекологических заболеваний». Москва, 6–9 июня 2023 г. М.: МЕДИ Ивент; 2023. С. 11–12. Режим доступа: https://mediexpo.ru/fileadmin/user_upload/content/pdf/thesis/nt2023-abstracts.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Хоперская ОВ. Скрининг рака шейки матки: акцент на предиктивности. В: Тезисы IV общероссийской научно-¬практической конференции акушеров--гинекологов «Оттовские чтения». Санкт-¬Петербург, 10–11 ноября 2022 г. М.: StatusPraesens; 2022. С. 51–52. Режим доступа: https://elibrary.ru/viveyz.</mixed-citation><mixed-citation xml:lang="en">Хоперская ОВ. Скрининг рака шейки матки: акцент на предиктивности. В: Тезисы IV общероссийской научно-¬практической конференции акушеров--гинекологов «Оттовские чтения». Санкт-¬Петербург, 10–11 ноября 2022 г. М.: StatusPraesens; 2022. С. 51–52. Режим доступа: https://elibrary.ru/viveyz.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Хоперская ОВ. Оптимизация цервикального скрининга. В: Тезисы III общероссийской научно-¬практической конференции для акушеров-¬гинекологов «Оттовские чтения». Санкт-¬Петербург, 12–13 ноября 2021 г. М.: StatusPraesens; 2022. С. 76–77. Режим доступа: https://www.elibrary.ru/pkllmu.</mixed-citation><mixed-citation xml:lang="en">Хоперская ОВ. Оптимизация цервикального скрининга. В: Тезисы III общероссийской научно-¬практической конференции для акушеров-¬гинекологов «Оттовские чтения». Санкт-¬Петербург, 12–13 ноября 2021 г. М.: StatusPraesens; 2022. С. 76–77. Режим доступа: https://www.elibrary.ru/pkllmu.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Хоперская ОВ, Киселева ЕВ, Енькова ЕВ, Туровский ЯА. Управление развитием системы органосберегающего подхода в лечении предрака шейки матки. В: Труды Четырнадцатой международной конференции. Москва, 27–28 сентября 2021 г. М.; 2021. С. 1768–1771. http://doi.org/10.25728/3253.2021.88.40.001.</mixed-citation><mixed-citation xml:lang="en">Хоперская ОВ, Киселева ЕВ, Енькова ЕВ, Туровский ЯА. Управление развитием системы органосберегающего подхода в лечении предрака шейки матки. В: Труды Четырнадцатой международной конференции. Москва, 27–28 сентября 2021 г. М.; 2021. С. 1768–1771. http://doi.org/10.25728/3253.2021.88.40.001.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Адамян ЛВ, Аполихина ИА, Артымук НВ, Ашрафян ЛА, Баранов ИИ, Байрамова ГР и др. Цервикальная интраэпителиальная неоплазия, эрозия и эктропион шейки матки: клинические рекомендации. М.; 2020. 54 с. Режим доступа: https://cr.minzdrav.gov.ru/recomend/597_1.</mixed-citation><mixed-citation xml:lang="en">Адамян ЛВ, Аполихина ИА, Артымук НВ, Ашрафян ЛА, Баранов ИИ, Байрамова ГР и др. Цервикальная интраэпителиальная неоплазия, эрозия и эктропион шейки матки: клинические рекомендации. М.; 2020. 54 с. Режим доступа: https://cr.minzdrav.gov.ru/recomend/597_1.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Grabowska AK, Riemer AB. The invisible enemy – how human papillomaviruses avoid recognition and clearance by the host immune system. Open Virol J. 2012;6:249–256. https://doi.org/10.2174/1874357901206010249.</mixed-citation><mixed-citation xml:lang="en">Grabowska AK, Riemer AB. The invisible enemy – how human papillomaviruses avoid recognition and clearance by the host immune system. Open Virol J. 2012;6:249–256. https://doi.org/10.2174/1874357901206010249.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Reyes-Hernández OD, Figueroa-González G, Quintas-Granados LI, Gutiérrez-Ruíz SC, Hernández-Parra H, Romero-Montero A et al. 3,3’-Diindolylmethane and indole-3-carbinol: potential therapeutic molecules for cancer chemoprevention and treatment via regulating cellular signaling pathways. Cancer Cell Int. 2023;23(1):180. https://doi.org/10.1186/s12935-023-03031-4.</mixed-citation><mixed-citation xml:lang="en">Reyes-Hernández OD, Figueroa-González G, Quintas-Granados LI, Gutiérrez-Ruíz SC, Hernández-Parra H, Romero-Montero A et al. 3,3’-Diindolylmethane and indole-3-carbinol: potential therapeutic molecules for cancer chemoprevention and treatment via regulating cellular signaling pathways. Cancer Cell Int. 2023;23(1):180. https://doi.org/10.1186/s12935-023-03031-4.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33. https://doi.org/10.3322/caac.21708.</mixed-citation><mixed-citation xml:lang="en">Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33. https://doi.org/10.3322/caac.21708.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Shen J, Li J, Yu P, Du G. Research Status and Hotspots of Anticancer Natural Products Based on the Patent Literature and Scientific Articles. Front Pharmacol. 2022;13:903239. https://doi.org/10.3389/fphar.2022.903239.</mixed-citation><mixed-citation xml:lang="en">Shen J, Li J, Yu P, Du G. Research Status and Hotspots of Anticancer Natural Products Based on the Patent Literature and Scientific Articles. Front Pharmacol. 2022;13:903239. https://doi.org/10.3389/fphar.2022.903239.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Gahtori R, Tripathi AH, Kumari A, Negi N, Paliwal A, Tripathi P et al. Anticancer plant-derivatives: deciphering their oncopreventive and therapeutic potential in molecular terms. Futur J Pharm Sci. 2023;9(1):14. https://doi.org/10.1186/s43094-023-00465-5.</mixed-citation><mixed-citation xml:lang="en">Gahtori R, Tripathi AH, Kumari A, Negi N, Paliwal A, Tripathi P et al. Anticancer plant-derivatives: deciphering their oncopreventive and therapeutic potential in molecular terms. Futur J Pharm Sci. 2023;9(1):14. https://doi.org/10.1186/s43094-023-00465-5.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Dehelean CA, Marcovici I, Soica C, Mioc M, Coricovac D, Iurciuc S et al. Plant-Derived Anticancer Compounds as New Perspectives in Drug Discovery and Alternative Therapy. Molecules. 2021;26(4):1109. https://doi.org/10.3390/molecules26041109.</mixed-citation><mixed-citation xml:lang="en">Dehelean CA, Marcovici I, Soica C, Mioc M, Coricovac D, Iurciuc S et al. Plant-Derived Anticancer Compounds as New Perspectives in Drug Discovery and Alternative Therapy. Molecules. 2021;26(4):1109. https://doi.org/10.3390/molecules26041109.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Ge J, Ge X, Li H. Resveratrol inhibits Treg/Th17 mediated tumor immune escape in mice with cervical cancer. Panminerva Med. 2020. https://doi.org/10.23736/S0031-0808.20.03900-2.</mixed-citation><mixed-citation xml:lang="en">Ge J, Ge X, Li H. Resveratrol inhibits Treg/Th17 mediated tumor immune escape in mice with cervical cancer. Panminerva Med. 2020. https://doi.org/10.23736/S0031-0808.20.03900-2.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Einbond LS, Zhou J, Wu HA, Mbazor E, Song G, Balick M et al. A novel cancer preventative botanical mixture, TriCurin, inhibits viral transcripts and the growth of W12 cervical cells harbouring extrachromosomal or integrated HPV16 DNA. Br J Cancer. 2021;124(5):901–913. https://doi.org/10.1038/s41416-020-01170-3.</mixed-citation><mixed-citation xml:lang="en">Einbond LS, Zhou J, Wu HA, Mbazor E, Song G, Balick M et al. A novel cancer preventative botanical mixture, TriCurin, inhibits viral transcripts and the growth of W12 cervical cells harbouring extrachromosomal or integrated HPV16 DNA. Br J Cancer. 2021;124(5):901–913. https://doi.org/10.1038/s41416-020-01170-3.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Vieira IRS, Tessaro L, Lima AKO, Velloso IPS, Conte-Junior CA. Recent Progress in Nanotechnology Improving the Therapeutic Potential of Polyphenols for Cancer. Nutrients. 2023;15(14):3136. https://doi.org/10.3390/nu15143136.</mixed-citation><mixed-citation xml:lang="en">Vieira IRS, Tessaro L, Lima AKO, Velloso IPS, Conte-Junior CA. Recent Progress in Nanotechnology Improving the Therapeutic Potential of Polyphenols for Cancer. Nutrients. 2023;15(14):3136. https://doi.org/10.3390/nu15143136.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Cheng J, Xiang J, Wei L, Zheng T, Wu J. Metabolomic Profiling and Assessment of Phenolic Compounds Derived from Vitis davidii Foex Cane and Stem Extracts. Int J Mol Sci. 2022;23(23):14873. https://doi.org/10.3390/ijms232314873.</mixed-citation><mixed-citation xml:lang="en">Cheng J, Xiang J, Wei L, Zheng T, Wu J. Metabolomic Profiling and Assessment of Phenolic Compounds Derived from Vitis davidii Foex Cane and Stem Extracts. Int J Mol Sci. 2022;23(23):14873. https://doi.org/10.3390/ijms232314873.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Liu J, Nie S, Gao M, Jiang Y, Wan Y, Ma X et al. Identification of EPHX2 and RMI2 as two novel key genes in cervical squamous cell carcinoma by an integrated bioinformatic analysis. J Cell Physiol. 2019;234(11):21260–21273. https://doi.org/10.1002/jcp.28731.</mixed-citation><mixed-citation xml:lang="en">Liu J, Nie S, Gao M, Jiang Y, Wan Y, Ma X et al. Identification of EPHX2 and RMI2 as two novel key genes in cervical squamous cell carcinoma by an integrated bioinformatic analysis. J Cell Physiol. 2019;234(11):21260–21273. https://doi.org/10.1002/jcp.28731.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Merlin JPJ, Rupasinghe HPV, Dellaire G, Murphy K. Role of Dietary Antioxidants in p53-Mediated Cancer Chemoprevention and Tumor Suppression. Oxid Med Cell Longev. 2021:9924328. https://doi.org/10.1155/2021/9924328.</mixed-citation><mixed-citation xml:lang="en">Merlin JPJ, Rupasinghe HPV, Dellaire G, Murphy K. Role of Dietary Antioxidants in p53-Mediated Cancer Chemoprevention and Tumor Suppression. Oxid Med Cell Longev. 2021:9924328. https://doi.org/10.1155/2021/9924328.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Hazafa A, Iqbal MO, Javaid U, Tareen MBK, Amna D, Ramzan A et al. Inhibitory effect of polyphenols (phenolic acids, lignans, and stilbenes) on cancer by regulating signal transduction pathways: a review. Clin Transl Oncol. 2022;24(3):432–445. https://doi.org/10.1007/s12094-021-02709-3.</mixed-citation><mixed-citation xml:lang="en">Hazafa A, Iqbal MO, Javaid U, Tareen MBK, Amna D, Ramzan A et al. Inhibitory effect of polyphenols (phenolic acids, lignans, and stilbenes) on cancer by regulating signal transduction pathways: a review. Clin Transl Oncol. 2022;24(3):432–445. https://doi.org/10.1007/s12094-021-02709-3.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Орлова СВ, Никитина ЕА, Карушина ЛИ, Пигарёва ЮА, Пронина ОЕ, Яценко ЕВ, Магомедова ХА. Индол-3-карбинол как потенциальный фактор антиканцерогенной защиты: позиция диетолога. Медицинский алфавит. 2020;(16):15–20. https://doi.org/10.33667/2078-5631-2020-16-15-20.</mixed-citation><mixed-citation xml:lang="en">Orlova SV, Nikitina EA, Karushina LI, Pigaryova YuA, Pronina OE, Yatsenko EV, Magomedova Kh A. Indole-3-carbinol as potential factor in anticarcinogenic protection: nutritionist’s position. Medical Alphabet. 2020;(16):15–20. (In Russ.) https://doi.org/10.33667/2078-5631-2020-16-15-20.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Хияева ВА. Опыт применения индолкарбинола при мастопатиях. Медицинский совет. 2019;(13):154–158. https://doi.org/10.21518/2079-701X-2019-13-154-158.</mixed-citation><mixed-citation xml:lang="en">Khiyaeva VA. Experience with indolecarbinol used to treat mastopathy. Meditsinskiy sovet. 2019;(13):154–158. (In Russ.) https://doi.org/10.21518/2079-701X-2019-13-154-158.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Hu H, Li F, Zhu F, Li J, Wang S, He Z et al. Indole-3-carbinol ameliorates ovarian damage in female old mice through Nrf2/HO-1 pathway activation. Biochem Pharmacol. 2024;223:116193. https://doi.org/10.1016/j.bcp.2024.116193.</mixed-citation><mixed-citation xml:lang="en">Hu H, Li F, Zhu F, Li J, Wang S, He Z et al. Indole-3-carbinol ameliorates ovarian damage in female old mice through Nrf2/HO-1 pathway activation. Biochem Pharmacol. 2024;223:116193. https://doi.org/10.1016/j.bcp.2024.116193.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Centofanti F, Alonzi T, Latini A, Spitalieri P, Murdocca M, Chen X et al. Indole-3-carbinol in vitro antiviral activity against SARS-Cov-2 virus and in vivo toxicity. Cell Death Discov. 2022;8(1):491. https://doi.org/10.1038/s41420-022-01280-2.</mixed-citation><mixed-citation xml:lang="en">Centofanti F, Alonzi T, Latini A, Spitalieri P, Murdocca M, Chen X et al. Indole-3-carbinol in vitro antiviral activity against SARS-Cov-2 virus and in vivo toxicity. Cell Death Discov. 2022;8(1):491. https://doi.org/10.1038/s41420-022-01280-2.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Pennarossa G, Arcuri S, Pasquariello R, Gandolfi F, Maranesi M, Brevini TAL. Cruciferous vegetable-derived indole-3-carbinol prevents coronavirus cell egression mechanisms in tracheal and intestinal 3D in vitro models. Phytochemistry. 2023;212:113713. https://doi.org/10.1016/j.phytochem.2023.113713.</mixed-citation><mixed-citation xml:lang="en">Pennarossa G, Arcuri S, Pasquariello R, Gandolfi F, Maranesi M, Brevini TAL. Cruciferous vegetable-derived indole-3-carbinol prevents coronavirus cell egression mechanisms in tracheal and intestinal 3D in vitro models. Phytochemistry. 2023;212:113713. https://doi.org/10.1016/j.phytochem.2023.113713.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Гусаков КИ, Назарова НМ, Абакарова ПР, Тарарыкова АА, Иванов ИА. Применение ресвератрола и индол-3-карбинола в качестве антипролиферативного метода профилактики ВПЧ-ассоциированных заболеваний. Медицинский совет. 2022;(16):151–159. https://doi.org/10.21518/2079-701X-2022-16-16-151-159.</mixed-citation><mixed-citation xml:lang="en">Gusakov KI, Nazarova NM, Abakarova PR, Tararykova AA, Ivanov IA. Antiproliferative effects of resveratrol and indole-3-carbinol in HPVassociated diseases prevention. Meditsinskiy Sovet. 2022;(16):151–159. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-16-151-159.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Williams DE. Indoles Derived From Glucobrassicin: Cancer Chemoprevention by Indole-3-Carbinol and 3,3’-Diindolylmethane. Front Nutr. 2021;8:734334. https://doi.org/10.3389/fnut.2021.734334.</mixed-citation><mixed-citation xml:lang="en">Williams DE. Indoles Derived From Glucobrassicin: Cancer Chemoprevention by Indole-3-Carbinol and 3,3’-Diindolylmethane. Front Nutr. 2021;8:734334. https://doi.org/10.3389/fnut.2021.734334.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Полозников АА, Муйжнек ЕЛ, Никулин СВ, Каприн АД, Ашрафян ЛА, Рожкова НИ, Лабазанова ПГ, Киселев ВИ. Противоопухолевая активность индол-3-карбинола в клетках рака молочной железы: фенотип – генетический паттерн – обращение ДНК-метилирования. Биотехнология. 2020;36(2):43–55. Режим доступа: https://www.elibrary.ru/hhdqgt.</mixed-citation><mixed-citation xml:lang="en">Poloznikov AA, Muyzhnek EL, Nikulin SV, Kaprin AD, Ashrafyan LA, Rozhkova NI, Labazanova PG, Kiselev VI. Antitumor activity of indole-3-carbinol in breast cancer cells: phenotype, genetic pattern, DNA methylation inversion. Biotekhnologiya. 2020;36(2):43–55. (In Russ.) Available at: https://www.elibrary.ru/hhdqgt.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Куценко ИИ, Боровиков ИО, Горринг ХИ, Магай АС, Горбулина АА. Опыт клинического применения дииндолилметана в лечении ассоциированного с вирусом папилломы человека цервикального поражения низкой степени. Медицинский совет. 2020;(3):25–31. https://doi.org/10.21518/2079-701X-2020-3-25-31.</mixed-citation><mixed-citation xml:lang="en">Kutsenko II, Borovikov IO, Gorring Khi, Magay AS, Gorbulina AA. Experience of clinical use of diindolylmethane in the treatment of HPV-associated low-grade cervical lesions. Meditsinskiy Sovet. 2020;(3):25–31. (In Russ.) https://doi.org/10.21518/2079-701X-2020-3-25-31.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Bell MC, Crowley-Nowick P, Bradlow HL, Sepkovic DW, SchmidtGrimminger D, Howell P et al. Placebo-controlled trial of indole-3-carbinol in the treatment of CIN. Gynecol Oncol. 2000;78(2):123–129. https://doi.org/10.1006/gyno.2000.5847.</mixed-citation><mixed-citation xml:lang="en">Bell MC, Crowley-Nowick P, Bradlow HL, Sepkovic DW, SchmidtGrimminger D, Howell P et al. Placebo-controlled trial of indole-3-carbinol in the treatment of CIN. Gynecol Oncol. 2000;78(2):123–129. https://doi.org/10.1006/gyno.2000.5847.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Круглова ДЮ, Цхай ВБ, Савченко АА. Оценка эффективности использования индол-3-карбинола в комплексной терапии у женщин с ВПЧассоциированной патологией шейки матки. Российский вестник акушера-гинеколога. 2011;11(5):63–66. Режим доступа: https://www.mediasphera.ru/issues/rossijskij-vestnik-akushera-ginekologa/2011/5/031726-61222011514.</mixed-citation><mixed-citation xml:lang="en">Kruglova DYu, Tskhai VB, Savchenko AA. Evaluation of the efficiency of using indole-3-carbinol in combination therapy in women with HPV-associated pathology of the cervix uteri. Russian Bulletin of Obstetrician-Gynecologist. 2011;11(5):63–66. (In Russ.) Available at: https://www.mediasphera.ru/issues/rossijskij-vestnik-akushera-ginekologa/2011/5/031726-61222011514.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Ampofo E, Schmitt BM, Menger MD, Laschke MW. Targeting the Microcirculation by Indole-3-carbinol and Its Main Derivate 3,3,’-diindolylmethane: Effects on Angiogenesis, Thrombosis and Inflammation. Mini Rev Med Chem. 2018;18(11):962–968. https://doi.org/10.2174/1389557518666180313100144.</mixed-citation><mixed-citation xml:lang="en">Ampofo E, Schmitt BM, Menger MD, Laschke MW. Targeting the Microcirculation by Indole-3-carbinol and Its Main Derivate 3,3,’-diindolylmethane: Effects on Angiogenesis, Thrombosis and Inflammation. Mini Rev Med Chem. 2018;18(11):962–968. https://doi.org/10.2174/1389557518666180313100144.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Mohammadi S, Memarian A, Sedighi S, Behnampour N, Yazdani Y. Immunoregulatory effects of indole-3-carbinol on monocyte-derived macrophages in systemic lupus erythematosus: A crucial role for aryl hydrocarbon receptor. Autoimmunity. 2018;51(5):199–209. https://doi.org/10.1080/08916934.2018.1494161.</mixed-citation><mixed-citation xml:lang="en">Mohammadi S, Memarian A, Sedighi S, Behnampour N, Yazdani Y. Immunoregulatory effects of indole-3-carbinol on monocyte-derived macrophages in systemic lupus erythematosus: A crucial role for aryl hydrocarbon receptor. Autoimmunity. 2018;51(5):199–209. https://doi.org/10.1080/08916934.2018.1494161.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Khan AS, Langmann T. Indole-3-carbinol regulates microglia homeostasis and protects the retina from degeneration. J Neuroinflammation. 2020;17(1):327. https://doi.org/10.1186/s12974-020-01999-8.</mixed-citation><mixed-citation xml:lang="en">Khan AS, Langmann T. Indole-3-carbinol regulates microglia homeostasis and protects the retina from degeneration. J Neuroinflammation. 2020;17(1):327. https://doi.org/10.1186/s12974-020-01999-8.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Peng C, Wu C, Xu X, Pan L, Lou Z, Zhao Y et al. Indole-3-carbinol ameliorates necroptosis and inflammation of intestinal epithelial cells in mice with ulcerative colitis by activating aryl hydrocarbon receptor. Exp Cell Res. 2021;404(2):112638. https://doi.org/10.1016/j.yexcr.2021.112638.</mixed-citation><mixed-citation xml:lang="en">Peng C, Wu C, Xu X, Pan L, Lou Z, Zhao Y et al. Indole-3-carbinol ameliorates necroptosis and inflammation of intestinal epithelial cells in mice with ulcerative colitis by activating aryl hydrocarbon receptor. Exp Cell Res. 2021;404(2):112638. https://doi.org/10.1016/j.yexcr.2021.112638.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">El-Daly SM, Gamal-Eldeen AM, Gouhar SA, Abo-Elfadl MT, El-Saeed G. Modulatory Effect of Indoles on the Expression of miRNAs Regulating G1/S Cell Cycle Phase in Breast Cancer Cells. Appl Biochem Biotechnol. 2020;192(4):1208–1223. https://doi.org/10.1007/s12010-020-03378-8.</mixed-citation><mixed-citation xml:lang="en">El-Daly SM, Gamal-Eldeen AM, Gouhar SA, Abo-Elfadl MT, El-Saeed G. Modulatory Effect of Indoles on the Expression of miRNAs Regulating G1/S Cell Cycle Phase in Breast Cancer Cells. Appl Biochem Biotechnol. 2020;192(4):1208–1223. https://doi.org/10.1007/s12010-020-03378-8.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Wang ML, Shih CK, Chang HP, Chen YH. Antiangiogenic activity of indole-3- carbinol in endothelial cells stimulated with activated macrophages. Food Chem. 2012;134(2):811–820. https://doi.org/10.1016/j.foodchem.2012.02.185.</mixed-citation><mixed-citation xml:lang="en">Wang ML, Shih CK, Chang HP, Chen YH. Antiangiogenic activity of indole-3- carbinol in endothelial cells stimulated with activated macrophages. Food Chem. 2012;134(2):811–820. https://doi.org/10.1016/j.foodchem.2012.02.185.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Lim HM, Park SH, Nam MJ. Induction of apoptosis in indole-3-carbinoltreated lung cancer H1299 cells via ROS level elevation. Hum Exp Toxicol. 2021;40(5):812–825. https://doi.org/10.1177/0960327120969968.</mixed-citation><mixed-citation xml:lang="en">Lim HM, Park SH, Nam MJ. Induction of apoptosis in indole-3-carbinoltreated lung cancer H1299 cells via ROS level elevation. Hum Exp Toxicol. 2021;40(5):812–825. https://doi.org/10.1177/0960327120969968.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Pal A, Kundu R. Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy. Front Microbiol. 2020;10:3116. https://doi.org/10.3389/fmicb.2019.03116.</mixed-citation><mixed-citation xml:lang="en">Pal A, Kundu R. Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy. Front Microbiol. 2020;10:3116. https://doi.org/10.3389/fmicb.2019.03116.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Chan CK, Aimagambetova G, Ukybassova T, Kongrtay K, Azizan A. Human Papillomavirus Infection and Cervical Cancer: Epidemiology, Screening, and Vaccination-Review of Current Perspectives. J Oncol. 2019:3257939. https://doi.org/10.1155/2019/3257939.</mixed-citation><mixed-citation xml:lang="en">Chan CK, Aimagambetova G, Ukybassova T, Kongrtay K, Azizan A. Human Papillomavirus Infection and Cervical Cancer: Epidemiology, Screening, and Vaccination-Review of Current Perspectives. J Oncol. 2019:3257939. https://doi.org/10.1155/2019/3257939.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Williams DE. Indoles Derived From Glucobrassicin: Cancer Chemoprevention by Indole-3-Carbinol and 3,3’-Diindolylmethane. Front Nutr. 2021;8:734334. https://doi.org/10.3389/fnut.2021.734334.</mixed-citation><mixed-citation xml:lang="en">Williams DE. Indoles Derived From Glucobrassicin: Cancer Chemoprevention by Indole-3-Carbinol and 3,3’-Diindolylmethane. Front Nutr. 2021;8:734334. https://doi.org/10.3389/fnut.2021.734334.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Arellano-Gutiérrez CV, Quintas-Granados LI, Cortés H, González Del Carmen M, Leyva-Gómez G, Bustamante-Montes LP et al. Indole-3-Carbinol, a Phytochemical Aryl Hydrocarbon Receptor-Ligand, Induces the mRNA Overexpression of UBE2L3 and Cell Proliferation Arrest. Curr Issues Mol Biol. 2022;44(5):2054–2068. https://doi.org/10.3390/cimb44050139.</mixed-citation><mixed-citation xml:lang="en">Arellano-Gutiérrez CV, Quintas-Granados LI, Cortés H, González Del Carmen M, Leyva-Gómez G, Bustamante-Montes LP et al. Indole-3-Carbinol, a Phytochemical Aryl Hydrocarbon Receptor-Ligand, Induces the mRNA Overexpression of UBE2L3 and Cell Proliferation Arrest. Curr Issues Mol Biol. 2022;44(5):2054–2068. https://doi.org/10.3390/cimb44050139.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Baez-Gonzalez AS, Carrazco-Carrillo JA, Figueroa-Gonzalez G, QuintasGranados LI, Padilla-Benavides T, Reyes-Hernandez OD. Functional effect of indole-3 carbinol in the viability and invasive properties of cultured cancer cells. Biochem Biophys Rep. 2023;35:101492. https://doi.org/10.1016/j.bbrep.2023.101492.</mixed-citation><mixed-citation xml:lang="en">Baez-Gonzalez AS, Carrazco-Carrillo JA, Figueroa-Gonzalez G, QuintasGranados LI, Padilla-Benavides T, Reyes-Hernandez OD. Functional effect of indole-3 carbinol in the viability and invasive properties of cultured cancer cells. Biochem Biophys Rep. 2023;35:101492. https://doi.org/10.1016/j.bbrep.2023.101492.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Pani S, Sahoo A, Patra A, Debata PR. Phytocompounds curcumin, quercetin, indole-3-carbinol, and resveratrol modulate lactate-pyruvate level along with cytotoxic activity in HeLa cervical cancer cells. Biotechnol Appl Biochem. 2021;68(6):1396–1402. https://doi.org/10.1002/bab.2061.</mixed-citation><mixed-citation xml:lang="en">Pani S, Sahoo A, Patra A, Debata PR. Phytocompounds curcumin, quercetin, indole-3-carbinol, and resveratrol modulate lactate-pyruvate level along with cytotoxic activity in HeLa cervical cancer cells. Biotechnol Appl Biochem. 2021;68(6):1396–1402. https://doi.org/10.1002/bab.2061.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Annaji M, Poudel I, Boddu SHS, Arnold RD, Tiwari AK, Babu RJ. Resveratrolloaded nanomedicines for cancer applications. Cancer Rep (Hoboken). 2021;4(3):e1353. https://doi.org/10.1002/cnr2.1353.</mixed-citation><mixed-citation xml:lang="en">Annaji M, Poudel I, Boddu SHS, Arnold RD, Tiwari AK, Babu RJ. Resveratrolloaded nanomedicines for cancer applications. Cancer Rep (Hoboken). 2021;4(3):e1353. https://doi.org/10.1002/cnr2.1353.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Yang MF, Yao X, Chen LM, Gu JY, Yang ZH, Chen HF et al. Synthesis and biological evaluation of resveratrol derivatives with anti-breast cancer activity. Arch Pharm. 2020;353(7):e2000044. https://doi.org/10.1002/ardp.202000044.</mixed-citation><mixed-citation xml:lang="en">Yang MF, Yao X, Chen LM, Gu JY, Yang ZH, Chen HF et al. Synthesis and biological evaluation of resveratrol derivatives with anti-breast cancer activity. Arch Pharm. 2020;353(7):e2000044. https://doi.org/10.1002/ardp.202000044.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">PLoS ONE Editors. Expression of Concern: Resveratrol Enhances Antitumor Activity of TRAIL in Prostate Cancer Xenografts through Activation of FOXO Transcription Factor. PLoS ONE. 2019;14(9):e0223138. https://doi.org/10.1371/journal.pone.0223138.</mixed-citation><mixed-citation xml:lang="en">PLoS ONE Editors. Expression of Concern: Resveratrol Enhances Antitumor Activity of TRAIL in Prostate Cancer Xenografts through Activation of FOXO Transcription Factor. PLoS ONE. 2019;14(9):e0223138. https://doi.org/10.1371/journal.pone.0223138.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Ashrafizadeh M, Rafiei H, Mohammadinejad R, Farkhondeh T, Samarghandian S. Anti-tumor activity of resveratrol against gastric cancer: a review of recent advances with an emphasis on molecular pathways. Cancer Cell Int. 2021;21(1):66. https://doi.org/10.1186/s12935-021-01773-7.</mixed-citation><mixed-citation xml:lang="en">Ashrafizadeh M, Rafiei H, Mohammadinejad R, Farkhondeh T, Samarghandian S. Anti-tumor activity of resveratrol against gastric cancer: a review of recent advances with an emphasis on molecular pathways. Cancer Cell Int. 2021;21(1):66. https://doi.org/10.1186/s12935-021-01773-7.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Nowicki A, Wawrzyniak D, Czajkowski M, Józkowiak M, Pawlak M, Wierzchowski M et al. Enhanced biological activity of liposomal methylated resveratrol analog 3’-hydroxy-3,4,5,4’-tetramethoxystilbene (DMU-214) in 3D patient-derived ovarian cancer model. Drug Deliv. 2022;29(1):2459–2468. https://doi.org/10.1080/10717544.2022.2103210.</mixed-citation><mixed-citation xml:lang="en">Nowicki A, Wawrzyniak D, Czajkowski M, Józkowiak M, Pawlak M, Wierzchowski M et al. Enhanced biological activity of liposomal methylated resveratrol analog 3’-hydroxy-3,4,5,4’-tetramethoxystilbene (DMU-214) in 3D patient-derived ovarian cancer model. Drug Deliv. 2022;29(1):2459–2468. https://doi.org/10.1080/10717544.2022.2103210.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Xiong H, Cheng J, Jiang S, Wen J, Jian Y, Wei L et al. The antitumor effect of resveratrol on nasopharyngeal carcinoma cells. Front Biosci (Landmark Ed). 2019;24(5):961–970. https://doi.org/10.2741/4761.</mixed-citation><mixed-citation xml:lang="en">Xiong H, Cheng J, Jiang S, Wen J, Jian Y, Wei L et al. The antitumor effect of resveratrol on nasopharyngeal carcinoma cells. Front Biosci (Landmark Ed). 2019;24(5):961–970. https://doi.org/10.2741/4761.</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Hao X, Sun X, Zhu H, Xie L, Wang X, Jiang N et al. Hydroxypropyl-βCyclodextrin-Complexed Resveratrol Enhanced Antitumor Activity in a Cervical Cancer Model: In Vivo Analysis. Front Pharmacol. 2021;12:573909. https://doi.org/10.3389/fphar.2021.573909.</mixed-citation><mixed-citation xml:lang="en">Hao X, Sun X, Zhu H, Xie L, Wang X, Jiang N et al. Hydroxypropyl-βCyclodextrin-Complexed Resveratrol Enhanced Antitumor Activity in a Cervical Cancer Model: In Vivo Analysis. Front Pharmacol. 2021;12:573909. https://doi.org/10.3389/fphar.2021.573909.</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Shen J, Li J, Yu P, Du G. Research Status and Hotspots of Anticancer Natural Products Based on the Patent Literature and Scientific Articles. Front Pharmacol. 2022;13:903239. https://doi.org/10.3389/fphar.2022.903239.</mixed-citation><mixed-citation xml:lang="en">Shen J, Li J, Yu P, Du G. Research Status and Hotspots of Anticancer Natural Products Based on the Patent Literature and Scientific Articles. Front Pharmacol. 2022;13:903239. https://doi.org/10.3389/fphar.2022.903239.</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Liu Z, Li Y, She G, Zheng X, Shao L, Wang P et al. Resveratrol induces cervical cancer HeLa cell apoptosis through the activation and nuclear translocation promotion of FOXO3a. Pharmazie. 2020;75(6):250–254. https://doi.org/10.1691/ph.2020.0386.</mixed-citation><mixed-citation xml:lang="en">Liu Z, Li Y, She G, Zheng X, Shao L, Wang P et al. Resveratrol induces cervical cancer HeLa cell apoptosis through the activation and nuclear translocation promotion of FOXO3a. Pharmazie. 2020;75(6):250–254. https://doi.org/10.1691/ph.2020.0386.</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Sun X, Fu P, Xie L, Chai S, Xu Q, Zeng L et al. Resveratrol inhibits the progression of cervical cancer by suppressing the transcription and expression of HPV E6 and E7 genes. Int J Mol Med. 2021;47(1):335–345. https://doi.org/10.3892/ijmm.2020.4789.</mixed-citation><mixed-citation xml:lang="en">Sun X, Fu P, Xie L, Chai S, Xu Q, Zeng L et al. Resveratrol inhibits the progression of cervical cancer by suppressing the transcription and expression of HPV E6 and E7 genes. Int J Mol Med. 2021;47(1):335–345. https://doi.org/10.3892/ijmm.2020.4789.</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Nadile M, Retsidou MI, Gioti K, Beloukas A, Tsiani E. Resveratrol against Cervical Cancer: Evidence from In Vitro and In Vivo Studies. Nutrients. 2022;14(24):5273. https://doi.org/10.3390/nu14245273.</mixed-citation><mixed-citation xml:lang="en">Nadile M, Retsidou MI, Gioti K, Beloukas A, Tsiani E. Resveratrol against Cervical Cancer: Evidence from In Vitro and In Vivo Studies. Nutrients. 2022;14(24):5273. https://doi.org/10.3390/nu14245273.</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Rauf A, Imran M, Butt MS, Nadeem M, Peters DG, Mubarak MS. Resveratrol as an anti-cancer agent: A review. Crit Rev Food Sci Nutr. 2018;58(9):1428–1447. https://doi.org/10.1080/10408398.2016.1263597.</mixed-citation><mixed-citation xml:lang="en">Rauf A, Imran M, Butt MS, Nadeem M, Peters DG, Mubarak MS. Resveratrol as an anti-cancer agent: A review. Crit Rev Food Sci Nutr. 2018;58(9):1428–1447. https://doi.org/10.1080/10408398.2016.1263597.</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Wang P, Wu Q, Peng Q, Kang Z, Xiao S, Zheng P et al. Comparative analysis of the molecular mechanism of inhibiting proliferation and migration in cervical cancer HeLa cell by curcumin and resveratrol. Nat Prod Res. 2023;37(23):4032–4037. https://doi.org/10.1080/14786419.2022.2162517.</mixed-citation><mixed-citation xml:lang="en">Wang P, Wu Q, Peng Q, Kang Z, Xiao S, Zheng P et al. Comparative analysis of the molecular mechanism of inhibiting proliferation and migration in cervical cancer HeLa cell by curcumin and resveratrol. Nat Prod Res. 2023;37(23):4032–4037. https://doi.org/10.1080/14786419.2022.2162517.</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang J, Liu Z, Zhou X, Peng F, Wang Z, Li F, Li M. Resveratrol Induces Apoptosis, Suppresses Migration, and Invasion of Cervical Cancer Cells by Inhibiting the Hedgehog Signaling Pathway. Biomed Res Int. 2022:8453011. https://doi.org/10.1155/2022/8453011.</mixed-citation><mixed-citation xml:lang="en">Jiang J, Liu Z, Zhou X, Peng F, Wang Z, Li F, Li M. Resveratrol Induces Apoptosis, Suppresses Migration, and Invasion of Cervical Cancer Cells by Inhibiting the Hedgehog Signaling Pathway. Biomed Res Int. 2022:8453011. https://doi.org/10.1155/2022/8453011.</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Shin HJ, Han JM, Choi YS, Jung HJ. Pterostilbene Suppresses both Cancer Cells and Cancer Stem-Like Cells in Cervical Cancer with Superior Bioavailability to Resveratrol. Molecules. 2020;25(1):228. https://doi.org/10.3390/molecules25010228.</mixed-citation><mixed-citation xml:lang="en">Shin HJ, Han JM, Choi YS, Jung HJ. Pterostilbene Suppresses both Cancer Cells and Cancer Stem-Like Cells in Cervical Cancer with Superior Bioavailability to Resveratrol. Molecules. 2020;25(1):228. https://doi.org/10.3390/molecules25010228.</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Chen X, Tian J, Zhao C, Wu Y, Li J, Ji Z et al. Resveratrol, a novel inhibitor of fatty acid binding protein 5, inhibits cervical cancer metastasis by suppressing fatty acid transport into nucleus and downstream pathways. Br J Pharmacol. 2024;181(11):1614–1634. https://doi.org/10.1111/bph.16308.</mixed-citation><mixed-citation xml:lang="en">Chen X, Tian J, Zhao C, Wu Y, Li J, Ji Z et al. Resveratrol, a novel inhibitor of fatty acid binding protein 5, inhibits cervical cancer metastasis by suppressing fatty acid transport into nucleus and downstream pathways. Br J Pharmacol. 2024;181(11):1614–1634. https://doi.org/10.1111/bph.16308.</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Chatterjee K, Mukherjee S, Vanmanen J, Banerjee P, Fata JE. Dietary Polyphenols, Resveratrol and Pterostilbene Exhibit Antitumor Activity on an HPV E6-Positive Cervical Cancer Model: An in vitro and in vivo Analysis. Front Oncol. 2019;9:352. https://doi.org/10.3389/fonc.2019.00352.</mixed-citation><mixed-citation xml:lang="en">Chatterjee K, Mukherjee S, Vanmanen J, Banerjee P, Fata JE. Dietary Polyphenols, Resveratrol and Pterostilbene Exhibit Antitumor Activity on an HPV E6-Positive Cervical Cancer Model: An in vitro and in vivo Analysis. Front Oncol. 2019;9:352. https://doi.org/10.3389/fonc.2019.00352.</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang B, Tian Q, Shu C, Zhao J, Xue M, Zhu S. Resveratrol Enhances the AntiCancer Effects of Cis-Platinum on Human Cervical Cancer Cell Lines by Activating the SIRT3 Relative Anti-Oxidative Pathway. Front Pharmacol. 2022;13:916876. https://doi.org/10.3389/fphar.2022.916876.</mixed-citation><mixed-citation xml:lang="en">Jiang B, Tian Q, Shu C, Zhao J, Xue M, Zhu S. Resveratrol Enhances the AntiCancer Effects of Cis-Platinum on Human Cervical Cancer Cell Lines by Activating the SIRT3 Relative Anti-Oxidative Pathway. Front Pharmacol. 2022;13:916876. https://doi.org/10.3389/fphar.2022.916876.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
